Sinovac Biotech Ltd.: SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil

Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved by the Brazilian

Related Keywords

Ecuador ,China ,Colombia ,Chile ,Brazil ,Chinese ,Brazilian , ,Brazilian Society Of Immunizations Sbim ,Brazilian Association Of Collective Health Abrasco ,Butantan Institute ,Brazilian Society Of Pneumology ,Brazilian Society Of Pediatrics ,Brazilian Health Regulatory Agency Anvisa ,Sinovac Biotech Ltd ,Brazilian Society Of Infectious Diseases ,Pr Team ,Sinovac Biotech ,Brazilian Health Regulatory Agency ,Brazilian Society ,Infectious Diseases ,Brazilian Association ,Collective Health ,Emergency Use ,Biotech Ltd ,Sinovac ,Biotech ,Covid ,Vaccine ,Uthorized ,Emergency ,Kids ,Ged ,